GE Vernova T&D Q1 FY27: Revenue up 38% YoY, PAT up 25% to ₹363 Cr as margins cool
PAT +24.65% YoY · revenue +38.04% · margins compressing · beat vs street
₹1,836.14 Cr
+38.04% YoY
₹362.99 Cr
+24.65% YoY
19.33%
-2.3pp YoY
₹14.18
GE Vernova T&D India's standalone Q1 FY27 (quarter ended 30 June 2026, unaudited) revenue rose 38.0% YoY to ₹1,836.1 Cr (₹1,330.1 Cr in Q1 FY26) and 12.2% QoQ (₹1,637.1 Cr in Q4 FY26). Net profit grew 24.7% YoY to ₹363.0 Cr (₹291.2 Cr) and 3.2% QoQ (₹351.8 Cr), with EPS at ₹14.18 versus ₹11.37 a year ago. Both lines topped Street consensus tracked by TradingView (~₹1,733 Cr revenue, ~₹13.14 EPS), and the revenue growth is consistent with management's prior guidance of continued expansion on a robust order backlog — management has not issued a specific numeric growth target, so this reads as a beat on trajectory rather than against a stated figure.
Q1 FY-2027 vs prior quarters
Profitability grew slower than revenue and margins compressed on both counts: net margin eased to 19.8% from 21.6% a year ago (21.0% last quarter), and EBITDA margin (PBT plus finance cost and depreciation, over revenue) fell to 27.4% from 29.1% YoY (27.5% QoQ). Even so, 27.4% sits above management's own guided mid-20s EBITDA range from the Q4 FY26 call, so the compression reads as normalisation from an unusually strong year-ago base rather than a guidance miss. There was no exceptional item this quarter, versus a ₹5.7 Cr exceptional credit in Q4 FY26 and a ₹63.6 Cr full-year FY26 charge tied to new labour-code provisioning — the YoY comparison is clean on both sides and reported PAT growth needs no adjustment.
The stock went into the print at ₹4,372, down 1.6% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 2 consecutive quarters; revenue is at a 6-quarter high.
Management provided strong forward-looking guidance, highlighting continued revenue growth driven by a robust order backlog. They anticipate maintaining mid-20s EBITDA margins and plan significant capital investments (over INR 10 billion) to expand manufacturing capacity through 2028. The strategic direction focuses on
— This quarter: beat
The board approved the results alongside notice for the September 9, 2026 AGM. During the quarter the company reported a ₹55 Cr capacity investment (May 2026), consistent with the >₹1,000 Cr capex plan through 2028 flagged on the prior call; a director's tenure ended in late July, after quarter-close. Management's own release frames the quarter as a solid start to the financial year, citing continued capex across HVDC, transformers, GIS, circuit breakers and instrument transformers — consistent with the 38% topline growth, though the release does not put a number on margins or order book. Brokerages (JPMorgan, Motilal Oswal, Emkay) have flagged a strong export mix, including a potential US data-centre-linked HVDC export order, as the driver behind elevated margins and raised target prices, though none of that is confirmed in this filing.
W1
EBITDA margin trajectory — 27.4% this quarter vs management's guided mid-20s range; watch whether it holds above 27% or reverts toward 25-26% as the >₹1,000 Cr capacity investment ramps through 2028.
W2
Order backlog conversion — management cites a robust order backlog as the growth driver; confirm in Q2 FY27 disclosures, alongside the US export order analysts (JPMorgan) have flagged but this filing does not confirm.
W3
Labour-code exceptional item — FY26 carried a ₹63.6 Cr provision; monitor for further adjustment once final labour-code rules are notified.
Standalone only — company has no subsidiary/associate/JV as of 30-Jun-2026 (note 6). No exceptional item this quarter vs a ₹5.73 Cr credit in Q4 FY26 and ₹63.57 Cr full-year FY26 labour-code charge (note 4). OCI includes a ₹68.61 Cr cash-flow-hedge fair-value gain, excluded from PAT. Figures converted from ₹ Million to ₹ Crore (÷10); prior-quarter figures cross-checked exactly against supplied context.
Backlog Strength Masks the Order Intake Cliff
Revenue jumped 38% and EBITDA margins held at guidance, but order intake collapsed 30% year-on-year, and two major deals worth ₹4,300 crore slipped into H2. The question isn't whether this quarter was good — it was — but whether it signals a structural slowdown in India's transmission demand.
The tension: execution met guidance, but the pipeline went quiet
GVT&D delivered exactly what it promised. Revenue ₹1,836 crore matched the implied run-rate from guidance (+38% YoY). EBITDA margin of 25.1% hit the midpoint of the mid-20s band. Free cash of ₹29.3 crore remained robust. The company is operationally excellent. But order intake tells a different story: Q1 orders of ₹11.4 crore fell 30% year-on-year, domestic TBCB was soft through March, and two transformational RPT deals — a ₹1,300 crore US data center order and a ₹3,000 crore approval from another utility — both slipped into Q2-Q3+. That gap between what the company executed and what it will execute next is the quarter's real story.
₹1,836 Cr
vs guidance +38% YoY | Delivered exactly
25.1%
vs mid-20s guidance | Hit midpoint
₹11.4 Cr
-30% YoY | Domestic TBCB soft Jan-Mar
₹4,300 Cr
US data center + ₹3K Cr approval pushed Q2+
Management claims vs. what the numbers say
Q1 revenue 38% YoY growth from strong execution
EBITDA margin 25.1% in line with mid-20s guidance
Order backlog ₹209.3 Cr = 3.5x annual revenue
Order intake ₹11.4 Cr soft due to Jan-Mar TBCB pipeline, now picking up
RPT orders ₹1,300 Cr + ₹3,000 Cr expected H1 FY27
The first three claims hold up entirely — the revenue, margin, and backlog are all exactly as management stated and the numbers prove. The fourth claim is partially credible: management is right that the TBCB pipeline was quiet in Jan-Mar and is recovering (pipeline 'much better' in June-July per the call). But soft orders in Q1 combined with only 6–7% growth guidance (not double-digit) suggests either the market is structurally slower or GVT&D is being selective in bidding to protect margins. The fifth claim is contradicted. Both major RPT opportunities have been deferred: the ₹1,300 crore US data center order is now expected Q2-Q3+ due to location and voltage specification changes; the ₹3,000 crore utility approval has been put on hold by the customer due to budget issues and will need re-approval at the AGM. Neither is 'lost,' but neither is imminent.
What changed on this call
Order intake guidance
₹7,000–8,000 Cr/year base order confidence
Same guidance, but Q1 only ₹6.5 Cr ex-RPT (annualizes ₹26 Cr); no growth assumed
Guidance reaffirmed but near-term execution risk visible
RPT catalysts
₹1,300 Cr US data center + ₹3,000 Cr approval in-flight for H1 FY27
Both delayed to Q2-Q3+ (US) or on hold pending re-approval (₹3K Cr)
Major H1 revenue catalysts withdrawn; H2 dependent
EBITDA guidance
Mid-20s% maintained through FY27
Same, but Q1 delivered 25.1% despite 400 bps gross margin compression
Confidence in leverage/cost mgmt high, but execution risk on commodity pass-through
Backlog quality
Mix of PSUs, state utilities, private sector
Private customers now 77% of backlog (vs trend); PSUs 21%, state utilities 2%
De-risking shift; lower political/execution risk but also lower average order size
The margin story: commodity pressure is real, pass-through lagging
Gross margin fell 400 basis points year-on-year (45.3% in FY26 to 41.3% in Q1 FY27). Management attributed this to three sources: lower export revenue share (1–1.5% impact, because a high-margin export order was completed in FY26); HV business ramp-up at lower gross margins (2–2.5% impact, offset by EBITDA leverage); and commodity cost underperformance (1–2% impact, where anticipated savings did not fully materialize). The explanation is credible, but the miss on commodity execution is a red flag. Management states that transformer contracts have IEEMA escalation clauses and new bids build in higher commodity costs prospectively, but execution on older orders lags by 18–24 months. If commodity volatility persists, margin headroom will compress further in the near term. EBITDA leverage (cutting 210 bps from gross to EBITDA, up from 140 bps in FY26) is helping hold the line at 25.1%, but that math only works if leverage continues.
Market positioning: price action, flows, valuation
The result was announced Aug 5, 2026 (pre-announcement close ₹4,372). The initial market reaction was positive — a day-1 gain of +1.73% with 53.5% delivery. But the pop faded: by day 3, the stock was down -0.96%, and by day 5 it had turned flat at +0.18%. That two-step fade is the market's own verdict on the print: strong revenue and margin delivery are real, but order intake cliff and RPT delays are a headwind. Current price sits at ₹4,316 (as of Aug 13), down -23.61% from its all-time high but up +70.93% from its 52-week low. The stock trades below its 20-day and 50-day moving averages (₹4,327 and ₹4,654 respectively) but above its 200-day (₹3,841), suggesting a held pullback rather than a rout. RSI is 59.5 (neutral), and volume is normal.
Institutional flows tell a mixed story. FII ownership has been steadily accumulating: it rose from 14.49% (Q1 FY26) to 22.89% (Q1 FY27), a gain of 8.4 percentage points over four quarters. The latest quarter saw FII add another 2.5 percentage points, consistent with the trend. By contrast, DII ownership has trimmed from 26.76% (Q1 FY26) to 18.47% (Q1 FY27), a loss of 8.3 percentage points. The most recent quarter saw DII trim a further 2.92 percentage points. Read together: foreign institutions are seeing value on the drawdown and buying; domestic institutions are cautious and selling. That's not a rout, but it's not universal enthusiasm either. The divergence suggests global investors are more comfortable with the backlog and long-term story than domestic investors, who are weighing near-term order risk.
Bull case vs. bear case
The honest read sits between: GVT&D is a world-class executor with a fortress balance sheet and a de-risked order book. Q1 delivery was excellent. But the order intake cliff and RPT delays are real, not noise. The market is pricing in single-digit revenue growth near-term and waiting for proof that H2 TBCB awards and RPT closures can re-accelerate the pipeline. FII accumulation on the pullback is a vote of confidence; DII trimming is a caution flag. Valuation at ₹4,316 (post-drawdown) is no longer expensive, but it's not a screaming buy either — it's fair for a company executing well on a slowing order pipeline.
Ranked risks: what should worry a holder
Order intake cliff doesn't reverse
HighH2 FY27 TBCB decisions (Aug-Sep) and pipeline announcements; if Q2-Q3 orders stay below ₹10 Cr/quarter, FY27 guidance at risk
RPT delays extend beyond H2 FY27
High₹1,300 Cr US data center and ₹3,000 Cr utility approvals; if both slip to FY28, revenue shortfall ~₹15–20 Cr and FY27 growth guidance at risk
Gross margin doesn't recover
MediumQ2-Q3 GM trend; if commodity savings continue to underperform and export mix stays low, GM stays below 42% and EBITDA leverage required to hold mid-20s gets tighter
Chinese GIS competition pressures pricing
MediumCompetitive bid outcomes in Q2-Q3 Power Grid tenders; local-content execution by Chinese suppliers; if pricing falls >5%, margin pressure spreads
Domestic market growth is structurally lower than 6–7%
MediumFull-year TBCB order intake vs ₹7,000–8,000 Cr guidance; if below ₹6,000 Cr, suggests market share loss or market contraction not captured in guidance
What to watch next quarter
1 · TBCB tender awards (Aug-Sep decisions)
Management flagged that the TBCB pipeline was soft Jan-Mar but 'much better' in June-July. Proof of recovery is order wins this quarter. Target: minimum ₹12–15 crore to show acceleration vs Q1's ₹6.5 crore.
2 · RPT order closures (₹1,300 Cr US data center + ₹3,000 Cr utility)
Management says the US data center order is under discussion and expected Q2-Q3; the ₹3,000 crore approval is on hold for budget and needs re-approval. Timing clarity and booking progress is the test.
3 · Gross margin recovery
Q1 GM of 41.3% was hit by export mix, HV ramp, and commodity underperformance. Q2-Q3 will show whether commodity cost build-in (18–24 month lag) starts to ease pressure, and whether export orders hold at 46% intake or revert to historical 33%.
4 · Chinese GIS competition impact
Four new GIS suppliers are approved for India. Actual bid outcomes in Q2-Q3 tenders will reveal whether local-content requirements (60–65%) are binding enough to protect GVT&D's pricing, or if pricing concessions are forced.
5 · Vallam capacity ramp (on track)
The ₹55 crore capex project for capacity expansion is tracking on plan; part of it was already in use in Q1 FY27. Completion by end-FY27 should support volume growth in FY28, but watch for any delays or cost overruns.
The honest read
GVT&D is not a story of deterioration. The company executed flawlessly in Q1 — revenue, margin, and cash all delivered as promised. The backlog is fortress-strong (₹209.3 crore = 3.5x revenue, 77% private customers, low political risk). Management has a proven track record of meeting guidance. But this quarter is not a step-change; it's a hold. The story has shifted from 'strong growth driven by backlog burn and order intake' to 'backlog burn masking an order intake cliff and waiting for H2 TBCB recovery and RPT closures.' That's a material shift in near-term momentum.
The market's verdict on the price action (fade from day-1 +1.73% to day-5 +0.18%) and the 23.61% drawdown from all-time high both say the same thing: investors are pricing in a near-term slowdown and want proof before buying. FII accumulation (now 22.89%, +8 pp in a year) on the pullback is a sign of structural confidence, but DII trimming (-8.3 pp) is a sign of domestic caution. That divergence will likely persist until H2 order wins resolve the debate.
Rating: **Hold**. The company deserves it on execution, backlog, and balance sheet, but the order intake risk is real and near-term catalysts are delayed. The stock is now fairly valued at ₹4,316 after the drawdown, not cheap — so it's not a buy on valuation anymore. The single number to track from here is Q2-Q3 order intake. If TBCB awards and RPT closures accelerate and orders get back to ₹15+ crore/quarter, the stock has 20–25% upside to ₹5,200–5,400. If orders stay soft and RPT delays extend, downside is ₹3,500–3,800. That's the range until H2 clarity.
Strong execution masks soft orders; margin hold amid headwinds
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Delivered Q1 ₹1,836 Cr revenue and 25.1% EBITDA margin matched guidance exactly. Order guidance (₹7,000-8,000 Cr base/year) maintained but dependent on TBCB pipeline acceleration in H2.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong revenue execution (+38% YoY) and margin maintenance (25.1% EBITDA in line with guidance) demonstrate operational discipline. However, order intake collapsed 30% YoY, two major RPT opportunities (₹4.3 Cr combined) have been deferred, and domestic TBCB growth expectations are capped at 6-7% (not double-digit). The ₹209.3 Cr backlog (3.5x revenue) provides multi-year cover but near-term growth visibility is dimmed by soft orders and delayed RPT awards. Rating reflects strong execution against a softening order backdrop.
₹1836.1 Cr
Revenue · +38% YoY₹363 Cr
Reported PAT · +24.7% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Q1 revenue 38% YoY growth from strong execution
METDelivered ₹1,836.1 Cr vs ₹1,330 Cr prior year = 38.0% YoY
EBITDA margin 25.1% in line with mid-20s guidance
METDelivered OPM 25.1%; matches guidance exactly; represents 210 bps compression vs FY26 45.3% gross margin
Order backlog ₹209.3 Cr = 3.5x annual revenue
MET₹209.3 Cr vs FY26 revenue ₹5,290 Cr (estimate) = ~3.95x recent run rate; provides multi-year visibility
Q1 order intake ₹11.4 Cr soft due to Jan-Mar TBCB pipeline, but now picking up
OVERSTATEDIntake down 30% YoY; June-July pipeline improving per management; credible, but near-term orders at risk
RPT approvals ₹1,300 Cr (US data center) + ₹3,000 Cr progressing
MISSBoth delayed: data center shifted to Q2-Q3 due to location/voltage changes; ₹3,000 Cr on hold by customer for budget reasons. Major miss on prior expectations.
Earnings quality
What changed since the last call
Order intake guidance
DowngradeNo numeric FY27 order target stated; prior ₹7,000-8,000 Cr/year maintained but no growth assumed. Q1 intake ₹11.4 Cr (down 30% YoY) vs implied 6-7% market growth suggests GE losing share or selective in bidding.
RPT order pipeline
Withdrawn₹3,000 Cr approval on hold by customer (budget); ₹1,300 Cr US data center deferred to Q2-Q3 due to location changes. Both major catalysts pushed out; creates H1 FY27 revenue risk.
EBITDA guidance
NeutralMid-20s maintained despite 400 bps gross margin hit and commoditized market. Confidence in leverage and cost management evident but not upgraded given order softness.
Backlog quality
UpgradePrivate customers now 77% vs prior calls (trend towards derisking); PSUs 21%, state utilities only 2%. Positive shift but no growth acceleration visible.
The Q&A
Analysts pressed hard on order intake collapse, RPT delays, commodity pass-through, and HVDC pipeline risk. Management held firm on guidance and backlog quality but offered no near-term order acceleration. On Chinese competition, CEO pivoted to 60%+ local-content moat. On margin lumpiness, CFO committed to mid-20s band but acknowledged 'trough' in Q1 (soothed but did not inspire).
RPT order status — Sameer Thakur, Ambit Capital
AnsweredNo part booked; under discussion by GE group entities with end customer; expect Q2-Q3 FY27 timeline.
RPT holdback — Sameer Thakur, Ambit Capital
AnsweredApproval put on hold by customer due to budget issues; will need re-approval at AGM when opportunity re-emerges.
HVDC pipeline risk — Sameer Thakur, Ambit Capital
PartialSouth Kalamb bidding happened; decision expected Aug-Sep. Expect 1-2 more projects in NCT. Pipeline remains strong; pace slightly delayed but not lost.
Export order surge — Parikshit Kandpal, HDFC Securities
AnsweredUS utility customer instrument transformer demand improved; 400 kV GIS opportunities from Spain/Morocco; better pipeline this quarter vs historical norms.
Domestic order softness — Parikshit Kandpal, HDFC Securities
PartialJan-Mar TBCB pipeline was soft; June-July pipeline much better. If large pipeline decided in July, ordering may spill to Q2/Q3. Too early to call.
Data center market opportunity — Amit Anwani, PL Capital
PartialData center orders not significant in current intake; only few product orders. Drawing board shows larger DC capacities planned; materialization in Q2-Q3 or later—TBD.
Full-year domestic order growth — Amit Anwani, PL Capital
AnsweredNot expecting double-digit; expect 6-7% growth this year. Market at same level or slight growth.
Margin guidance maintenance — Amit Anwani, PL Capital
AnsweredYes, maintaining mid-20s EBITDA guidance for FY27. No reason to deviate right now.
Chinese GIS competition — Jason Soans, IDBI Capital
PartialMonitoring; Chinese have 60-65% local-content requirement (Make in India clause). Capability to deliver 18-month timelines with local content TBD. Impact on negotiations unknown until bids received.
Gross margin breakdown — Jason Soans, IDBI Capital
Answered(1) 1-1.5% lower export share + high-margin export order in FY26; (2) 2-2.5% HV business ramp (lower GM, better EBITDA leverage); (3) Commodity prices, lower execution savings than anticipated.
Export vs domestic backlog — Anuj Jain, Globe Capital
PartialExport in backlog ~10-15% range; do not give exact breakup (confidential). ₹11.4 Cr Q1 orders: ~₹5.2 Cr exports, ~₹6.5 Cr third-party/domestic.
RPT approval expiry — Shirom Kapur, Jefferies
AnsweredYes; separate. ₹1,300 Cr for US data center; ₹3,000 Cr for different project (not US). Both pending. ₹3,000 Cr expires by AGM; only ₹1,300 Cr left after.
Base order confidence FY27 — Shirom Kapur, Jefferies
AnsweredYes, remain confident.
Commodity pricing in new tenders — Shirom Kapur, Jefferies
AnsweredTwo parts: (1) Transformer bids get price escalation formula (IEEMA); not impacted. (2) Other businesses: we estimate commodity costs prospectively; execution lag means new cost builds in future tenders, impact 18-24 months later when projects execute. Disciplined costing maintained.
Margin lumpiness forward — Subhadip Mitra, Nuvama
AnsweredQ1 EBITDA in line with mid-20s guidance despite commodity headwinds. Continue to maintain mid-20s band for FY27.
Global capacity (Prolec/US) — Subhadip Mitra, Nuvama
PartialYes, it will benefit. Exact TAM/mix depends on individual opportunities; difficult to predict.
Order confidence near-term — Ibram, individual investor
AnsweredTBCB pipeline was soft Jan-Mar; now June-July pipeline picked up. Gives confidence order numbers will be better.
Multi-year vision — Venkatesh S, LogicTree
DodgedForward-looking statement; cannot share on call. Backlog ₹209 Cr = 3.5x last FY revenue. Growth trajectory robust next few years; HVDC meaningful growth from FY29 onward.
Capex guidance — Venkatesh S, LogicTree
Answered₹10 Cr announced in FY26. ₹29.3 Cr cash available; ₹13 Cr committed (₹10 Cr capex, ₹2.5 Cr dividend). ₹16 Cr surplus; options under evaluation but nothing firmed yet.
Competitive advantage — Venkatesh S, LogicTree
AnsweredTechnology, Lean, localization.
Tier 2 supplier competition — Sameer Thakur, Ambit Capital
PartialTier 2 competition exists but product-dependent. Circuit breakers, GIS, automation, software—Tier 2 limited. Some domains have Tier 2 risk, others do not.
Pricing in new orders vs commodities — Sameer Thakur, Ambit Capital
PartialPass-through of commodity cost increases; not extra margin pass-through. Commodity increase is market phenomenon affecting all competitors.
STATCOM pipeline — Umesh Raut, Nomura
AnsweredYes, should pick up. Khavda generation loss should create opportunities for grid stability.
Capacity allocation — Umesh Raut, Nomura
PartialClose tracking of opportunities by delivery timeline, maturity stage. Conscious decisions on bid targeting. Some factories loaded; others have growth room. Consistent position.
TBCB timeline impact — Mahesh Patil, ICICI Securities
AnsweredCapex not impacted. Orders have definite timeframe. Ordering cycle may stretch if 30 months—customers take longer to decide (3-4 months vs 1-2 months at 18-24 months).
Segment margin profiles — Mahesh Patil, ICICI Securities
PartialConfidential. Export margins generally 4-6% higher than domestic; no other segment breakup given.
Vallam project timeline — Arunachalam, individual investor
PartialPart of capacity in Q1 FY27; balance by end of FY27.
Demand-supply oversupply risk — Pratik Dharmshi, Union Mutual Fund
PartialDomestic only: yes, oversupply risk. But global energy transition has shortfall. New capacity will feed export/global market. India market will grow. With exports, balance of supply-demand retained.
HVDC addressable market — Jason Soans, IDBI Capital
DodgedProject under bidding; cannot share numbers. Varies by project (1,000 km line vs 2,000 km line changes share).
Guidance
Domestic market growth 6-7% this year; not double-digit
MediumTBCB pipeline soft Jan-Mar, recovering June-July. Base order intake confidence ₹7,000-8,000 Cr/year maintained; no numeric FY27 revenue target stated.
EBITDA mid-20s% (reaffirmed) for FY27
HighQ1 delivered 25.1%; gross margin compression (-400 bps vs FY26) offset by HV business EBITDA leverage and execution discipline. Commodity and export headwinds acknowledged but mgmt states disciplined costing will manage.
₹10 Cr capacity expansion (announced FY26); on track
HighMostly greenfield within existing facilities (no new land needed); Vallam project part in Q1 FY27, balance by end FY27. ₹16 Cr surplus cash post-capex & dividend available for M&A/other options.
Risks the call surfaced
Order intake cliff
HighQ1 orders ₹11.4 Cr (down 30% YoY). Domestic TBCB soft Jan-Mar. Base order guidance ₹7,000-8,000 Cr/year but Q1 only ₹6.5 Cr ex-RPT. H2 recovery required.
RPT order delays
High₹1,300 Cr US data center order deferred to Q2-Q3+ (location/voltage changes). ₹3,000 Cr approval on hold by customer (budget issues); expires at AGM, needs re-approval.
Gross margin compression
MediumGross margin 41.3% vs 45.3% FY26 (400 bps). Commodity price headwinds, lower export share, HV business ramp-up all contributing. Risk of further slippage if commodities remain elevated.
HVDC pipeline delays
MediumLakadia on hold, Begunia converted to EHVAC, South Kalamb still under bidding (decision Aug-Sep). HVDC backlog is back-ended; meaningful growth deferred to FY29.
Chinese competition
Medium4 Chinese GIS suppliers approved for Indian market. 60-65% local-content requirement and 18-month delivery capability untested. Risk of pricing pressure and market share loss in GIS segment.
Management
Score 7/10. Clear on operational metrics and detailed on margin drivers. Evasive on multi-year targets and strategy (deflects as 'forward-looking'). Transparent on order delays and competitive risks. Strong Q1 revenue delivery (+38% YoY) and margin maintenance (25.1% vs guidance). Backlog conversion tracking well. Capex execution on schedule. But order intake miss (-30% YoY) signals market challenge or selective bidding.
1 · Q2 FY27 (Jul-Sep 2026)
TBCB tender awards; RPT orders (US data center, other projects)
2 · H2 FY27 (Oct 2026 onwards)
HVDC project order closure (South Kalamb, Barmer bidding underway)
3 · FY29 (2028-29)
HVDC backlog execution acceleration; meaningful PAT uplift expected
Rating reflects strong execution against a softening order backdrop.